Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Forte Biosciences, Inc. | 70,000 | reported | 01 Mar 2018 | tx 5+212,246 |
| PROGENICS PHARMACEUTICALS INC | 0 | reported | 19 Jun 2020 | tx 4+207,214−207,214 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Jun 2020 | OTHER | PROGENICS PHARMACEUTICALS INC | 125,000 | — | deriv |
| 19 Jun 2020 | OTHER | PROGENICS PHARMACEUTICALS INC | 82,214 | — | deriv |
| 02 Mar 2020 | GRANT_AWARD | PROGENICS PHARMACEUTICALS INC | 82,214 | 0.00 USD | deriv |
| 01 Feb 2019 | GRANT_AWARD | PROGENICS PHARMACEUTICALS INC | 125,000 | 0.00 USD | deriv |
| 01 Mar 2018 | GRANT_AWARD | Forte Biosciences, Inc. | 70,000 | 0.00 USD | deriv |
| 08 Dec 2017 | OTHER | Forte Biosciences, Inc. | 2,500 | 8.50 USD | |
| 26 May 2017 | GRANT_AWARD | Forte Biosciences, Inc. | 130,000 | 0.00 USD | deriv |
| 19 Apr 2017 | PURCHASE | Forte Biosciences, Inc. | 2,500 | 10.00 USD | |
| 12 Apr 2017 | GRANT_AWARD | Forte Biosciences, Inc. | 7,246 | 0.00 USD | deriv |